GlycanAge LTD 

Unlocking the human glycome for preventative health and longevity

OWNER

Gordan Lauc (See Profile)


OWNER

Nikolina Lauc (See Profile)


Sector

Diagnostics

Stage

Sales, licensing phases

Country

United Kingdom


We're the only people in the world who can look at this part of human biology at scale

Our lab generates 85% of the global human glycome output

Patented technology. 6 patents, 4 first inventor patents. Unique opportunity for glycan biomarker IP accumulation

200+ scientific publications to back our claims

Glycan biomarkers uniquely encapsulate genetic, epigenetic and environmental factors driving longevity for every human

Status

Approved

IP Type

Patent

Time

12 years

Countries

Austria
Belgium
Denmark
Finland
France
Germany
Italy
Netherlands
Spain
United Kingdom

Coverage

Method for the analysis of N-glycans attached to immunoglobulin G from human blood plasma and its use

Know more of this patent

Status

Approved

IP Type

Patent

Time

14 years

Countries

USA

Coverage

Method for the analysis of N-glycans attached to immunoglobulin G from human blood plasma and its use

Know more of this patent

Status

Pending

IP Type

PCT

Time

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

Diagnostic process for the determination of perimenopause or menopause status via analysis of the igg glycome

Know more of this patent

Status

Approved

IP Type

Patent

Time

16 years

Countries

USA

Coverage

Procedure of predicting type 2 diabetes development through analysis of N-glycans attached to the plasma proteins of a healthy person

Know more of this patent

Status

Pending

IP Type

Patent

Time

15 years

Countries

Austria
Belgium
Denmark
Finland
France
Germany
Italy
Netherlands
Spain
United Kingdom

Coverage

Procedure of predicting type 2 diabetes development through analysis of n-glycans attached to the plasma proteins of a healthy person

Know more of this patent

Status

Approved

IP Type

Patent

Time

16 years

Countries

China

Coverage

Procedure of predicting type 2 diabetes development through analysis of N-glycans attached to the plasma proteins of a healthy person

Know more of this patent

Status

Approved

IP Type

Trademark

Time

50 years

Countries

USA
United Kingdom

Coverage

Scientific and technological services, namely, scientific research, analysis and testing in the field of glycomics and glycoproteomics

Design and development of computer hardware and software medical services, namely, providing information in the field of aging

Know more of this patent

This information is confidential, do not share or copy.

Under evaluation at least till: 2nd of February 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar